EANS-News: Hypoport AG increases the size of its Management Board
Berlin, den (euro adhoc) -
The two executive directors of the Hypoport subsidiary Dr. Klein & Co AG have today been appointed to the Management Board of Hypoport AG. This means that all four of the Hypoport Group's business units will be represented on the Management Board. The Supervisory Board has today approved Thomas Kretschmar's previously announced intention to step down from the Management Board and has acknowledged his plans to stand as a candidate to join the Supervisory Board.
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement.
Board of Directors (Appointments and Changes)
Subtitle: The two executive directors of the Hypoport subsidiary Dr. Klein & Co AG have today been appointed to the Management Board of Hypoport AG. This means that all four of the Hypoport Group's business units will be represented on the Management Board. The Supervisory Board has today approved Thomas Kretschmar's previously announced intention to step down from the Management Board and has acknowledged his plans to stand as a candidate to join the Supervisory Board.
The Supervisory Board of Hypoport AG has today (24 March) approved Mr Kretschmar's intention to step down from the Management Board before his term of appointment expires and has relieved him of his responsibilities with effect from 31 May this year. A major shareholder has in the meantime filed a motion to have Mr Kretschmar elected to the Supervisory Board at this year's Annual Shareholders' Meeting on 4 June. Mr Kretschmar intends to comply with this motion and stand as a candidate for a position on the Supervisory Board.
In addition to Ronald Slabke and Thilo Wiegand - the remaining members of the Management Board - Stephan Gawarecki and Hans Peter Trampe have today been appointed to the Management Board for the period from 1 June 2010 to 31 December 2014. They will also continue to serve as executive directors of the subsidiary Dr. Klein & Co AG. Ronald Slabke has been appointed CEO of Hypoport AG's new Management Board - which will consist of four members - with effect from 1 June this year. Furthermore, from the 1 January 2011 to the 31 December 2015 Mr. Slabke was appointed to another term.
Mr Kretschmar's current responsibilities will be split among several members of the new Management Board.
Information on Hypoport AG The Berlin-based Hypoport Group is an online provider of financial products and services and employs approximately 450 people. Its shares have been listed in the Prime Standard segment of the Frankfurt Stock Exchange (Deutsche Börse) since October 2007. The business model used by Hypoport AG is based on two mutually supporting pillars: the sale of financial products (Dr. Klein & Co. AG) and the provision of a transactions platform for the brokerage of financial products over the internet. The EUROPACE B2B financial marketplace operated by Hypoport is Germany's biggest online transactions platform for selling financial products. A fully integrated system links more than 40 product suppliers with several thousand financial advisers, thereby enabling products to be sold swiftly and directly. The highly automated processes used on this platform generate significant cost advantages. Around 400 financial transactions per day are now settled via EUROPACE. Hypoport AG publishes its monthly house price index (HPX) based on actual transaction data.
A list of the banks and financial service providers represented on the online platform as well as the Company's 2008 annual report can be downloaded at www.hypoport.com.
end of announcement euro adhoc
Further inquiry note:
Michaela Reimann
Group Communications Manager
Telefon: +49 (0) 30 42086 1936
E-Mail: michaela.reimann@hypoport.de
Branche: Financial & Business Services
ISIN: DE0005493365
WKN: 549336
Börsen: Frankfurt / regulated dealing/prime standard